Financial Advisors Network’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.5K Buy
41,638
+21,054
+102% +$19.5K ﹤0.01% 208
2026
Q1
$12.5K Hold
20,584
﹤0.01% 204
2025
Q4
$19.8K Buy
20,584
+4,184
+26% +$5.92K ﹤0.01% 196
2025
Q3
$28.5K Buy
16,400
+2,779
+20% +$5.45K ﹤0.01% 196
2025
Q2
$28.5K Buy
+13,621
New +$26.2K ﹤0.01% 190

Other funds holding HUMA

Financial Advisors Network's HUMA Position: Q2 2026 in Review

Financial Advisors Network increased its Humacyte (HUMA) stake by 102% in Q2 2026, buying an estimated $19.5K and bringing the position to 41,638 shares worth $32.5K. The position accounts for ﹤0.01% of the portfolio, ranked #208.

Financial Advisors Network first reported a position in HUMA in Q2 2025 and has held it in 5 quarters since. 163 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Financial Advisors Network held 41,638 shares of Humacyte worth $32.5K as of Q2 2026.
  • Financial Advisors Network bought 21,054 Humacyte shares in Q2 2026, an estimated $19.5K.
  • Humacyte made up ﹤0.01% of Financial Advisors Network's portfolio in Q2 2026, its #208 holding.
  • Financial Advisors Network first reported a position in Humacyte in Q2 2025 and has held it in 5 quarters since.
  • 163 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Financial Advisors Network's 13F filing for Q2 2026, filed 14 Aug 2026.